⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

HIMS

Hims & Hers Health, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

27.90USD

-0.2700 (-0.96%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 27.90
P/E—
Dvd Ind Yld—
P/B20.09
P/S2.5
Curr EV/T12M EBITDA-715.1
Mkt Cap (USD)6.5B
Curr EV (USD)7.3B
2)

Per Share Data

EPS T12M-0.63
DPS—
Bk Val Per Sh1.39
Rev/Sh11.12
Cash/Sh3.61
Curr Shares Out224.9M
FCF/Sh0.27
3)

Cash Flow Analysis

P/CF24.7
Curr P/FCF105.8
CF/NI-1.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales10.2%
Eff Interest Rate0.0%
4)

Growth Potential

Dil EPS 1Y Gr-3.8%
Cap 1Y Gr13.5%
BPS 1Y Gr4.1%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr59.0%
FCF 1Y Gr-71.0%
Assets 1Y Gr204.5%
5)

Profitability

EBITDA-0.1B
EBIT-0.2B
Operating Margin-6.0%
Pretax Margin-6.3%
Net Margin-5.5%
ROA-5.2%
ROE-32.0%
ROC-7.2%
Asset Turnover0.94
6)

Structure

Current Ratio0.93
Quick Ratio0.82
Debt/Assets42.6%
Debt/Com Eq477.1%
Net Debt/EBITDA-13.91
Tot Debt/Capital82.7%
Gross Margin68.4%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.